It seems like we just finished discussing a 2020 full-year revenue blowout for many of the top U.S. cannabis operators, such as Green Thumb Industries, Curaleaf, and Cresco Labs. Recent better-than-expected revenue for Canadian grower OrganiGram (NASDAQ: OGI) in particular demonstrates some signs of life for a company whose stock has been less than spirited lately. A positive quarterly sales surprise is a good sign, but it may not be representative of the bigger picture for the company.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting